NCX-701 (NicOx)

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


NicOx is developing NCX-701, a nitric oxide-releasing derivative of paracetamol (acetaminophen), for the potential treatment of inflammation and pain. The compound is currently undergoing phase III clinical trials.

Original languageEnglish (US)
Pages (from-to)755-759
Number of pages5
JournalCurrent Opinion in Investigational Drugs
Issue number7
StatePublished - Jul 1 2004

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'NCX-701 (NicOx)'. Together they form a unique fingerprint.

Cite this